A Study of Experimental Medication BMS-986235 in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Mediators of Inflammation

In brief

This is a study of experimental medication BMS-986235 in healthy subjects.

Key facts

Study ID

NCT03335553

Run by

Bristol-Myers Squibb

People needed

122

Starts

2017-11-15

Expected to finish

2021-07-02

Last updated by the study team

2022-03-31

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients must be normal healthy volunteers as determined by no clinically significant deviations in medical history, physical examination, ECGs, vital signs, and clinical laboratory determinations
• Patients must have a body mass index (BMI) of 18 - 30 mg/kg2, inclusive

You may not qualify if…

• Patients that are pregnant
• Patient with any significant acute or chronic medical illness
• Patient with a current or recent (within 3 months of study treatment administration) gastrointestinal disease that could affect absorption
• Patient with any surgery within 12 weeks of study treatment administration
• Patient with any gastrointestinal surgery that could impact upon the absorption of study drug
• Patient who donated blood to a blood bank or in a clinical study (except a screening visit) within 12 weeks of study drug administration (within 2 weeks for plasma only)
• Patient who received a blood transfusion within 12 weeks of study drug administration
• Other protocol defined inclusion/exclusion criteria apply

Where it is running

• Anaheim Clinical Trials — Anaheim, California, United States
• PRA Health Sciences — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.